SOD1 and amyotrophic lateral sclerosis: For instance, recently, it was demonstrated that synthesized constructs are able to activate and exploit the endogenous lysosomal chaperone-mediated autophagy (CMA) pathway specifically against pathogenic SOD1 aggregates, determining a decrease in aggregates and improving the outcome of ALS in vivo [39].